Geode Capital Management, LLC Jasper Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.68 - $1.54 $41,498 - $93,981	-61,027 Reduced 6.32%	904,477 $633,000
Q2 2023 Aug 11, 2023	SELL	$1.19 - $1.79 $124,723 - $187,609	-104,810 Reduced 9.79%	965,504 $1.32 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $1.4 Million - $2.58 Million	942,898 Added 740.02%	1,070,314 $1.94 Million
Q4 2022 Feb 13, 2023	SELL	$0.46 - $8.9 $146 - $2,830	-318 Reduced 0.25%	127,416 $60,000
Q1 2022 May 13, 2022	BUY	$2.96 - $8.01 $31,624 - $85,578	10,684 Added 9.13%	127,734 $453,000
Q4 2021 Feb 11, 2022	BUY	$7.21 - $16.42 $843,930 - $1.92 Million	117,050 New	117,050 $918,000

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $843M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.